Expert Review of Anti-Infective Therapy

Papers
(The TQCC of Expert Review of Anti-Infective Therapy is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Detection of SARS-CoV-2 by antigen ELISA test is highly swayed by viral load and sample storage condition149
Tocilizumab effectiveness in mechanically ventilated COVID-19 patients (T-MVC-19 Study): a multicenter real-world evidence70
Optic and peripheral neuropathy associated with short and prolonged administration of tedizolid: a review55
Antiviral drugs for coronavirus disease 2019 (COVID-19): a systematic review with network meta-analysis51
Overdose deaths and HIV infections among people who use drugs: shared determinants and integrated responses50
A narrative review on drug development for the management of antimicrobial- resistant infection crisis in Japan: the past, present, and future49
Efficacy and acceptability of different anti-fungal interventions in oropharyngeal or esophageal candidiasis in HIV co-infected adults: a pilot network meta-analysis46
Investigating forthcoming strategies to tackle deadly superbugs: current status and future vision44
Wide-spectrum antibiotic prophylaxis guarantees optimal outcomes in drowned donor kidney transplantation39
Prevalence and determinants of self-medication with antibiotics among general population in Afghanistan39
Recurrent bloodstream infections after allogeneic hematopoietic cell transplantation38
Analysis of clinical characteristics and prognostic factors of ARDS caused by community-acquired pneumonia in people with different immune status37
Pro-, pre- and synbiotics for the prevention of incidental ventilator-associated pneumonia among critically ill patients: a systematic review and meta-analysis of randomized controlled trials37
Genetic heterogeneity of group A rotaviruses: a review of the evolutionary dynamics and implication on vaccination33
Can we use azithromycin eye drops for gonococcal ophthalmia prophylaxis in the United States?31
Is the world crippled by antimicrobial resistance, or simply lacking information?31
Hospital-acquired bacterial pneumonia in critically ill patients: from research to clinical practice31
Computational analysis of target genes in monkeypox virus infection and potential therapeutic precursors29
Overcoming clinical challenges in the management of invasive fungal infections in low- and middle-income countries (LMIC)28
Identification of antibiotic consumption targets for the management of Clostridioides difficile infection in hospitals- a threshold logistic modelling approach28
Health literacy, knowledge, household disposal, and misuse practices of antibiotics among UAE residents: a nationwide cross-sectional study27
Carbapenem-resistant Klebsiella pneumoniae : the role of plasmids in emergence, dissemination, and evolution of a major clinical challenge27
Clinical utility of procalcitonin in implementation of procalcitonin-guided antibiotic stewardship in the South-East Asia and India: evidence and consensus-based recommendations27
Prediction and prevention of preterm birth in pregnant women living with HIV on antiretroviral therapy26
Host-directed therapies for malaria and tuberculosis: common infection strategies and repurposed drugs26
The clinical application of traditional Chinese medicine NRICM101 in hospitalized patients with COVID-1923
Immunomodulatory markers and therapies for the management of infant respiratory syncytial virus infection22
Comparing prolonged infusion to intermittent infusion strategies for beta-lactam antibiotics in patients with gram-negative bacterial infections: a systematic review and meta-analysis22
Real-life experience of treating HCV co-infection among HIV-infected population in Egypt: single-center experience21
Clinical effectiveness of oral antiviral agents for treating non-hospitalized COVID-19 patients with chronic kidney disease21
Neonatal ocular prophylaxis in the United States: is it still necessary?20
How can we tackle the overuse of antibiotics in low- and middle-income countries?20
Exploring thresholds and interaction effects among antibiotic usage, covariates, and their effect on antibiotic resistance using an extended-spectrum β-Lactamase–producing Klebsiella pneumoniae20
Janus kinase inhibitors for hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials19
Understanding the genetic basis of immune responses to fungal infection18
Updates in the management of respiratory virus infections in ICU patients: revisiting the non-SARS-CoV-2 pathogens18
Visceral leishmaniasis elimination in India: progress and the road ahead18
Complications in community acquired pneumonia: magnitude of problem, risk factors, and management in pediatric age17
Mitigation of insufficient hospital workforce and personal protective equipment in the anti-COVID-19 campaign in mainland China17
Monoclonal antibodies for the treatment of COVID-19 infection in children16
Treatment strategies for OXA-48-like and NDM producing Klebsiella pneumoniae infections15
Old biomarkers in tuberculosis management: are they still useful? a systematic review15
Recent advances in the understanding of enterovirus A71 infection: a focus on neuropathogenesis15
Interaction of zincite, alpha-terpineol, geranyl acetate, linalool, myrcenol, terpinolene, and thymol with virulence factors of Escherichia coli, Mycobacterium tuberculosis, Pseudomonas14
Biosimilars as antivirals: opportunities and challenges14
New advances in the treatments of drug-resistant tuberculosis14
Molecular detections of coronavirus: current and emerging methodologies14
Drug recommendation for optimization on treatment outcome for MDR/RR-TB based on a multi-center, large scale, retrospective cohort study in China14
The efficacy and safety of complement C5a inhibitors for patients with severe COVID-19: a systematic review and meta-analysis13
Interrupting HIV transmission networks: how can we design and implement timely and effective interventions?13
Clostridioides difficile infection in inflammatory bowel disease: a clinical review13
Strategies to improve the diagnosis and clinical treatment of dermatophyte infections12
Vitamin D and immuno-pathology of COVID-19: many interactions but uncertain therapeutic benefits12
Improving management of febrile neutropenia in oncology patients: the role of artificial intelligence and machine learning12
Part 1: Understanding the role of Malassezia spp. in skin disorders: Malassezia yeasts as commensal or pathogenic organisms of human and a12
Real-world discontinuations due to neuropsychiatric symptoms in people living with HIV treated with second-generation integrase inhibitors: a systematic review12
The efficacy and safety of ceftolozane-tazobactam in the treatment of GNB infections: a systematic review and meta-analysis of clinical studies12
The antifungal pipeline for invasive fungal diseases: what does the future hold?12
Identification of active compounds of traditional chinese medicine derived from maxing shigan decoction for COVID-19 treatment: a meta-analysis and in silico study11
Antibiofilm and antimicrobial activity of curcumin-chitosan nanocomplexes and trimethoprim-sulfamethoxazole onAchromobacter, Burkholderia, andStenotrophomonasisolates11
Vitamin D attenuates COVID-19 complications via modulation of proinflammatory cytokines, antiviral proteins, and autophagy11
Therapeutic drug monitoring (TDM) in real-time: a need for the present future11
Treatment of cryptosporidiosis: nitazoxanide yes, but we can do better11
Part 2: Understanding the role of Malassezia spp. in skin disorders: pathogenesis of Malassezia associated skin infections11
Bacterial co-infections, secondary infections and antimicrobial use among hospitalized COVID-19 patients in the sixth wave in Pakistan: findings and implications11
Therapeutic strategies to address monkeypox11
Multicenter surveillance of in vitro activities of cefepime-zidebactam, cefepime-enmetazobactam, omadacycline, eravacycline, and comparator antibiotics against Enterobacterales, Pseudomonas 11
Impact of the COVID-19 pandemic on the utilisation and quality of antibiotic use in the Scottish primary care setting: a population-based segmented interrupted time-series analysis10
Sulbactam-durlobactam for the treatment of Acinetobacter baumannii-calcoaceticus complex10
The value of infectious disease modeling and trend assessment: a public health perspective10
Emerging and alternative strategies for the treatment of nontuberculous mycobacterial infections10
Emerging issues on Staphylococcus aureus endocarditis and the role in therapy of daptomycin plus fosfomycin10
Acanthamoeba Keratitis: an update on amebicidal and cysticidal drug screening methodologies and potential treatment with azole drugs10
Monotherapy versus combination for the treatment of Stenotrophomonas maltophilia: a multicenter cohort study10
NSAIDs/nitazoxanide/azithromycin repurposed for COVID-19: potential mitigation of the cytokine storm interleukin-6 amplifier via immunomodulatory effects10
Evaluating diagnostic tools, outcome measures and antibiotic approach in diabetic foot osteomyelitis: a scoping review and narrative synthesis9
Vitamin D attenuates biofilm-associated infections via immunomodulation and cathelicidin expression: a narrative review9
Analysis of antimicrobial drug usage in psychiatric specialized hospitals during the pandemic in China9
Potential activity of nanomaterials to combat SARS-CoV-2 and mucormycosis ‎coinfection‎9
Overcoming challenges in the management of recurrent urinary tract infections9
Comparison of effectiveness and safety of nirmatrelvir/ritonavir versus sotrovimab for COVID-19: a systematic review and meta-analysis9
Alternative drugs for the treatment of gonococcal infections: old and new9
Evaluation of truenat assays for the diagnosis of pulmonary and extrapulmonary tuberculosis: a systematic review and meta-analysis9
Effects of supplementation with low-dose group B vitamins on clinical and biochemical parameters in critically ill patients with COVID-19: a randomized clinical trial9
Economic impact of managing invasive mold disease with isavuconazole compared with liposomal amphotericin B followed by posaconazole in Spain9
Phage therapy: resurrecting a historical solution for the contemporary challenge of rising antibiotic resistance in Latin America8
Waking up to the Naegleria threat: urgent measures needed to protect public health in Pakistan8
Adverse effects of antibiotics in children with cancer: are short-course antibiotics for febrile neutropenia part of the solution?8
Outpatient treatment options to address the SARS-CoV-2 variant Omicron8
Cross-testing of direct-action antivirals, universal vaccines, or search for host-level antivirals: what will sooner lead to a generic capability to combat the emerging viral pandemics?8
Reviewing novel treatment options for carbapenem-resistant Enterobacterales8
Comparative efficacy and safety of antiviral traditional Chinese medicine injections for viral pneumonia: a systematic review and network meta-analysis8
An assessment of the index of rational drug prescribing for severe acute respiratory infections among hospitalised children in Northern Nigeria: a retrospective study8
Langya henipavirus outbreak8
Acute bacterial skin and skin structure infections in pediatric patients: potential role of dalbavancin8
Corticosteroids in SARS-COV2 infection: certainties and uncertainties in clinical practice8
Tackling antimicrobial resistance in sub-Saharan Africa: challenges and opportunities for implementing the new people-centered WHO guidelines8
Preventing healthcare-related infections among older adults: a focus on cross-transmission of antibiotic-resistant bacteria7
Improving empiric antibiotic prescribing in pediatric bloodstream infections: a potential application of weighted-incidence syndromic combination antibiograms (WISCA)7
Evaluation of favipiravir in the treatment of COVID-19 based on the real-world7
Surveillance and prevention of healthcare-associated infections: best practices to prevent ventilator-associated events7
What is the impact of SARS-CoV-2 infection during pregnancy on child immunity?7
Multidrug-resistant Klebsiella pneumoniae: mechanisms of resistance including updated data for novel β-lactam-β-lactamase inhibitor combinations7
Can the immunological system of the upper respiratory tract, improved by physical exercise, act as a first immunological barrier against SARS-CoV-2?7
Practices, Knowledge, and Attitudes of Nephrologists Towards Prescribing and Monitoring Vancomycin at Dialysis Centers7
Impact of some antiviral drugs on health care utilization for patients with COVID-19: a systematic review and meta-analysis7
The impacts of the national centralized drug procurement policy on the use of policy-related antibiotic agents: the case of Shaanxi province, China7
Drugs repurposing for SARS-CoV-2: new insight of COVID-19 druggability7
Indian consensus on the management of carbapenem-resistant enterobacterales infection in critically ill patients II (ICONIC II)7
How do we best manage Clostridioides difficle infections in the elderly?7
Evaluation of Namibia’s antiretroviral therapy guidelines’ recommendations for switching from first-line to second-line, using predictors of first-line treatment failure: an exploratory study7
How do we change our approach to COVID with the changing face of disease?7
The circadian rhythm of viruses and its implications on susceptibility to infection7
0.098673820495605